Skip to content
Cite as: De Vuyst, Geert (16 November 2022) Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis. Geert De Vuyst. https://geertdevuyst.be/en/publication/2020-garami-hyperthermia-induced-by-transient-receptor-potential-vanilloid-1-trpv1-antagonists-in-human-clinical-trials/

Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis

Article English Educated
TitleHyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysisAuthor(s)Garami, A., Shimansky, Y. P., Rumbus, Z., Vizin, R. C. L., Farkas, N., Hegyi, J., Szakacs, Z., Solymar, M., Csenkey, A., Chiche, D. A., Kapil, R., Kyle, D. J., Van Horn, W. D., Hegyi, P., & Romanovsky, A. A.JournalPharmacology & TherapeuticsVolume208Year of publication2020Pages107474DOIhttps://doi.org/10.1016/j.pha ... PublisherElsevier BVCite asGarami, A., Shimansky, Y. P., Rumbus, Z., Vizin, R. C. L., Farkas, N., Hegyi, J., Szakacs, Z., Solymar, M., Csenkey, A., Chiche, D. A., Kapil, R., Kyle, D. J., Van Horn, W. D., Hegyi, P., & Romanovsky, A. A. (2020). Hyperthermia induced by transient receptor potential vanilloid‑1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta‑analysis. Pharmacology & Therapeutics, 208, 107474. https://doi.org/10.1016/j.pharmthera.2020.107474

I currently provide training courses in French and Dutch.

Klik door naar geertdevuyst.be voor het aanbod opleidingen.

Découvrez les formations en français sur geertdevuyst.fr